Drug lookup
Drug reference

Ethinylestradiol, Etonogestrel

Progestogen · Contraception

Also known as NuvaRing, SyreniRing

ProgestogenContraception
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Combination hormonal contraceptives prevent ovulation by suppressing LH and FSH levels, thereby inhibiting the mid-cycle LH surge and diminishing endogenous steroid levels. This synergistic action of estrogen and progestin consistently suppresses ovulation. Progestin also plays a major role by diminishing the frequency of GnRH pulses, which are essential for LH pulse frequency and ovulation.

Indications

Contraception

Dosing

Adult
Insert one vaginal ring and leave in place for 3 consecutive weeks, followed by a 7-day ring-free interval. A new ring is inserted after this 7-day interval. If the ring is expelled for more than 3 hours during week 1 or 2, rinse and reinsert; use additional barrier precautions for 7 days.…

Pharmacokinetics

Onset
Full contraceptive protection may take 7 days if initiated later than day 5 of the menstrual cycle, or after re-insertion following an extended ring-free interval or expulsion.
Duration
The ring is used for 3 weeks, providing continuous hormone release. Contraceptive protection can extend up to 4 weeks of continuous use.

Other Progestogen drugs

Ask House about Ethinylestradiol, Etonogestrel

Continue into a citation-backed clinical answer with the drug context already attached.